BioSpace News Archive

Medovex Corporation Initiates Move to List on the OTCQB Market

The Company expects its shares will be accepted to trade on OTCQB under the symbol “MDVX” effective as early November 16, 2017.

November 15, 2017
·
4 min read
Business

BioSyent Releases Results for Third Quarter and First Nine Months of 2017

Third quarter (Q3) 2017 Net Revenues of $5,403,600 increased by 13% versus Q3 2016.

November 15, 2017
·
5 min read
Policy

Biotricity FDA Submission Update - Nov. 15, 2017

The company expects to receive further communication from the FDA within 30 days.

November 15, 2017
·
4 min read
Policy

Akcea and Ionis Announce Acceptance of Marketing Applications in U.S., EU and Canada for Volanesorsen for the Treatment of FCS

FDA Prescription Drug User Fee Act goal date set for August 30, 2018.

November 15, 2017
·
10 min read
Business

Akers Biosciences Announces Q3 2017 Earnings

Total revenues were $2.6 million compared with $4.0 million for the nine months ended September 30, 2016.

November 15, 2017
·
35 min read
Business

Delcath Announces Third Quarter 2017 Financial Results

Revenue for the third quarter of 2017 was $0.7 million, an increase of 75% from $0.4 million for the third quarter of 2016.

November 15, 2017
·
12 min read
BioCapital

Emergent BioSolutions Announces Notice of Termination of Conversion Rights of 2.875% Convertible Senior Notes Due 2021

As of November 13, 2017, approximately $250 million aggregate principal amount of the Notes were outstanding.

November 15, 2017
·
4 min read
Business

Proteostasis Therapeutics Reports Third Quarter 2017 Results and Provides CF Portfolio Update

Revenue was $1.6 million for the three months ended September 30, 2017, compared to $1.7 million for the three months ended September 30, 2016.

November 15, 2017
·
12 min read
Business

Genmab Achieves $25M Milestone for First Commercial Sale of DARZALEX® (daratumumab) in Japan and Updates Financial Guidance

First commercial sale of DARZALEX in Japan triggers USD 25 million in milestone payments from Janssen.

November 15, 2017
·
8 min read
Genetown

Leap Therapeutics Announces $18M Private Placement Offering

Upon closing of the transaction, Leap will sell 2,958,094 shares of unregistered common stock.

November 15, 2017
·
5 min read